Cargando…
Attenuated humoral response against SARS‐CoV‐2 mRNA vaccination in allogeneic stem cell transplantation recipients
Antibody persistence several months after severe acute respiratory syndrome coronavirus 2 (SARS‐CoV‐2) mRNA vaccination in allogeneic stem cell transplantation recipients remains largely unknown. We sequentially evaluated the humoral response to two doses of mRNA vaccines in 128 adult recipients and...
Autores principales: | Toya, Takashi, Atsuta, Yuya, Sanada, Takahiro, Honda, Tomoko, Sadato, Daichi, Sekiya, Noritaka, Kogure, Hiroko, Takakuwa, Sonomi, Onai, Daishi, Shingai, Naoki, Shimizu, Hiroaki, Najima, Yuho, Kobayashi, Takeshi, Ohashi, Kazuteru, Harada, Yuka, Kohara, Michinori, Doki, Noriko |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9538567/ https://www.ncbi.nlm.nih.gov/pubmed/36161681 http://dx.doi.org/10.1111/cas.15603 |
Ejemplares similares
-
A third dose of COVID‐19 mRNA vaccine induces limited humoral response in stem cell transplant recipients who got two vaccine doses before transplant
por: Toya, Takashi, et al.
Publicado: (2022) -
Impact of lung function impairment after allogeneic hematopoietic stem cell transplantation
por: Kishida, Yuya, et al.
Publicado: (2022) -
Impact of gene alterations on clinical outcome in young adults with myelodysplastic syndromes
por: Konishi, Tatsuya, et al.
Publicado: (2023) -
Archival bone marrow smears are useful in targeted next-generation sequencing for diagnosing myeloid neoplasms
por: Sadato, Daichi, et al.
Publicado: (2021) -
Phase I trial of myeloablative conditioning with 3‐day total marrow and lymphoid irradiation for leukemia
por: Ogawa, Hiroaki, et al.
Publicado: (2022)